Artificial Cells, Nanomedicine, and Biotechnology (Dec 2022)

Protective effect and mechanism of low P50 haemoglobin oxygen carrier on isolated rat heart

  • Wentao Zhou,
  • Shen Li,
  • Shasha Hao,
  • Honghui Zhang,
  • Tao Li,
  • Wanjing Li,
  • Jiaxin Liu,
  • Hong Wang,
  • Chengmin Yang

DOI
https://doi.org/10.1080/21691401.2021.2017947
Journal volume & issue
Vol. 50, no. 1
pp. 121 – 129

Abstract

Read online

The protection of the isolated heart is very important in heart transplantation surgery, meanwhile, the ischaemia/reperfusion (I/R) of the isolated heart is the main cause of its damage. A timely supply of oxygen can significantly improve the prevention of myocardial ischaemia, however, the cardioprotective solution does not have an oxygen supply function. Haemoglobin Based on Oxygen Carriers (HBOCs) is a kind of nano-oxygen drug, which can effectively and timely supply oxygen to hypoxic organs and tissues. However, the oxygen-carrying and releasing capacity (P50) is different with different HBOCs. The aim of our study was to investigate whether STS (a kind of cardioprotective solution, St Thomas Solution) +different P50 HBOCs provide superior myocardial protection and decrease myocardial injury compared to only STS in rats Langendorff isolated heart perfusion model. The results showed that STS + HBOCs can improve cardiac function at 37 °C for 35 min and 120 min, and reduce myocardial infarctions, pathological changes, and apoptosis of cardiomyocytes, and the STS + low P50 HBOCs is more effective than the other two higher P50 HBOCs. We further demonstrated the outstanding protective effect of STS + low P50 HBOCs on cardiac function, reducing myocardial infarctions and apoptosis of cardiomyocytes in rat Langendorff isolated heart perfusion model.

Keywords